Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 24, 2022
Patent Application Number
16927601
Date Filed
July 13, 2020
Patent Citations
Patent Primary Examiner
CPC Code
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
